317 related articles for article (PubMed ID: 32428792)
21. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
[TBL] [Abstract][Full Text] [Related]
22. 10-N-heterocylic aryl-isoxazole-amides (AIMs) have robust anti-tumor activity against breast and brain cancer cell lines and useful fluorescence properties.
Weaver MJ; Stump S; Campbell MJ; Backos DS; Li C; Reigan P; Adams E; Beall HD; Natale NR
Bioorg Med Chem; 2020 Nov; 28(22):115781. PubMed ID: 33038788
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, Computational Docking Study, and Biological Evaluation of a Library of Heterocyclic Curcuminoids with Remarkable Antitumor Activity.
Laali KK; Greves WJ; Zwarycz AT; Correa Smits SJ; Troendle FJ; Borosky GL; Akhtar S; Manna A; Paulus A; Chanan-Khan A; Nukaya M; Kennedy GD
ChemMedChem; 2018 Sep; 13(18):1895-1908. PubMed ID: 30079563
[TBL] [Abstract][Full Text] [Related]
24. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, biological evaluation of benzoyl amide derivatives containing nitrogen heterocyclic ring as potential VEGFR-2 inhibitors.
Shen FQ; Shi L; Wang ZF; Wang CR; Chen JJ; Liu Y; Qiu HY; Zhu HL
Bioorg Med Chem; 2019 Sep; 27(17):3813-3824. PubMed ID: 31327679
[TBL] [Abstract][Full Text] [Related]
26. Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells.
Tu HY; Huang AM; Teng CH; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Sep; 19(18):5670-8. PubMed ID: 21852140
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromene.
Alblewi FF; Okasha RM; Hritani ZM; Mohamed HM; El-Nassag MAA; Halawa AH; Mora A; Fouda AM; Assiri MA; Al-Dies AM; Afifi TH; El-Agrody AM
Bioorg Chem; 2019 Jun; 87():560-571. PubMed ID: 30928878
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, characterization, anticancer evaluation and mechanisms of cytotoxic activity of novel 3-hydroxy-3-pyrrolin-2-ones bearing thenoyl fragment: DNA, BSA interactions and molecular docking study.
Joksimović N; Petronijević J; Janković N; Baskić D; Popović S; Todorović D; Matić S; Bogdanović GA; Vraneš M; Tot A; Bugarčić Z
Bioorg Chem; 2019 Jul; 88():102954. PubMed ID: 31054428
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of p53 through induction of MDM2 degradation: Anthraquinone analogs.
Draganov AB; Yang X; Anifowose A; De La Cruz LKC; Dai C; Ni N; Chen W; De Los Santos Z; Gu L; Zhou M; Wang B
Bioorg Med Chem; 2019 Sep; 27(17):3860-3865. PubMed ID: 31324563
[TBL] [Abstract][Full Text] [Related]
32. Design and Syntheses of Novel Fluoroporphyrin-Anthraquinone Complexes as Antitumor Agents.
Yang GL; Zhao SF; Chen NY; Li S
Chem Pharm Bull (Tokyo); 2016; 64(9):1310-4. PubMed ID: 27581635
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents.
Li Z; Luo M; Cai B; Haroon-Ur-Rashid ; Huang M; Jiang J; Wang L; Wu L
Eur J Med Chem; 2018 Sep; 157():665-682. PubMed ID: 30125725
[TBL] [Abstract][Full Text] [Related]
34. Tri-armed ligands of G-quadruplex on heteroarene-fused anthraquinone scaffolds: Design, synthesis and pre-screening of biological properties.
Tikhomirov AS; Tsvetkov VB; Kaluzhny DN; Volodina YL; Zatonsky GV; Schols D; Shchekotikhin AE
Eur J Med Chem; 2018 Nov; 159():59-73. PubMed ID: 30268824
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and anticancer structure activity relationship investigation of cationic anthraquinone analogs.
Shrestha JP; Fosso MY; Bearss J; Chang CW
Eur J Med Chem; 2014 Apr; 77():96-102. PubMed ID: 24631728
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of five-membered heterocycles fused to cyclopenta[c]thiophene as new antitumor agents.
Dallemagne P; Khanh LP; Alsaïdi A; Varlet I; Collot V; Paillet M; Bureau R; Rault S
Bioorg Med Chem; 2003 Apr; 11(7):1161-7. PubMed ID: 12628643
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antitumor activity of cyclopentane-fused anthraquinone derivatives.
Tikhomirov AS; Sinkevich YB; Dezhenkova LG; Kaluzhny DN; Ilyinsky NS; Borshchevskiy VI; Schols D; Shchekotikhin AE
Eur J Med Chem; 2024 Feb; 265():116103. PubMed ID: 38176358
[TBL] [Abstract][Full Text] [Related]
38. 1-Hydroxyanthraquinones Containing Aryl Substituents as Potent and Selective Anticancer Agents.
Sirazhetdinova NS; Savelyev VA; Frolova TS; Baev DS; Klimenko LS; Chernikov IV; Oleshko OS; Sarojan TA; Pokrovskii AG; Shults EE
Molecules; 2020 May; 25(11):. PubMed ID: 32486108
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.
Huang K; Jiang L; Liang R; Li H; Ruan X; Shan C; Ye D; Zhou L
Eur J Med Chem; 2019 Apr; 168():45-57. PubMed ID: 30798052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
